| Residential College | false |
| Status | 已發表Published |
| Progress in the pharmaceutical study of Radix puerariae | |
Li X.; Wan J.-B. ; Li M.-Y.; Wang Y.-T.
| |
| 2010 | |
| Source Publication | Chinese Journal of New Drugs
 |
| Volume | 19Issue:8Pages:662 |
| Abstract | Atherosclerosis, a progressive disease characterized by the accumulation of lipids and fibrous elements in the large arteries, underlies the vast majority of cardiovascular disease and causes more death and disability worldwide than any other disease. The growing reports show that Radix puerariae(Gegeng), one of the most famous Chinese medicines, can inhibit the progression of atherosclerotic lesions. Isoflavonoids, such as puerarin, daidzein and daidzin, were considered as the main active components in Radix puerariae. In the present paper, the atheroprotective effects of Radix puerariae and its components have been reviewed and discussed. |
| Keyword | Atherosclerosis Daidzein Daidzin Puerarin Radix puerariae |
| URL | View the original |
| Language | 中文Chinese |
| The Source to Article | Scopus |
| Fulltext Access | |
| Document Type | Journal article |
| Collection | Institute of Chinese Medical Sciences |
| Affiliation | Institute of Chinese Medical Science, University of Macau, 331200, Macau |
| First Author Affilication | University of Macau |
| Recommended Citation GB/T 7714 | Li X.,Wan J.-B.,Li M.-Y.,et al. Progress in the pharmaceutical study of Radix puerariae[J]. Chinese Journal of New Drugs, 2010, 19(8), 662. |
| APA | Li X.., Wan J.-B.., Li M.-Y.., & Wang Y.-T. (2010). Progress in the pharmaceutical study of Radix puerariae. Chinese Journal of New Drugs, 19(8), 662. |
| MLA | Li X.,et al."Progress in the pharmaceutical study of Radix puerariae".Chinese Journal of New Drugs 19.8(2010):662. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment